
|Videos|September 15, 2015
Will There Be Hesitancy to Prescribe Biosimilars?
Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.
Advertisement
Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.
This video was recorded at the 2015 NACDS Total Store Expo.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
NK3 as a Drug Target: From Scientific Discovery to Guideline-Recognized Therapy
2
Sonrotoclax Plus Zanubrutinib Produces Deep MRD Responses in Treatment-Naive CLL
3
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
4
KNDy Neurons Explained: The Brain Science Behind Hot Flashes and New Treatment Targets
5































































































































